www.fgks.org   »   [go: up one dir, main page]

Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation

Eur Respir J. 2021 Feb 11;57(2):2003198. doi: 10.1183/13993003.03198-2020. Print 2021 Feb.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Idiopathic Pulmonary Fibrosis* / drug therapy
  • Idiopathic Pulmonary Fibrosis* / genetics
  • Indoles
  • Mutation
  • Pyridones / therapeutic use
  • Telomere*
  • Treatment Outcome

Substances

  • Indoles
  • Pyridones
  • pirfenidone
  • nintedanib